Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on May 9, 2025
Nelipak® Healthcare Packaging expande operaciones en Costa Rica
GlobeNewswire
·
May 9, 2025
CRANSTON, Rhode Island, May 09, 2025 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak®”), un proveedor líder global de soluciones de empaque para el sector de salud para dispositivos médicos, diagnóstico, administración de medicamentos farmacéuticos y …
Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités
GlobeNewswire
·
May 9, 2025
- Essai de phase II portant sur le pétosemtamab en association avec le pembrolizumab en 1re ligne de traitement dans le CETC r/m exprimant PD-L1 en cours et données cliniques mises à jour lors de la réunion annuelle 2025 de l’ASCO® - Sur la base de l’ …
Merus gibt Finanzergebnisse für das erste Quartal 2025 bekannt und informiert über den aktuellen Geschäftsverlauf
GlobeNewswire
·
May 9, 2025
- Phase-II-Studie mit Petosemtamab in Kombination mit Pembrolizumab in der Erstlinienbehandlung des PD-L1-positiven rezidivierenden/metastasierenden Kopf-Hals-Plattenepithelkarzinoms läuft, Aktualisierung der klinischen Daten auf der ASCO®-Jahrestagung …
PhenQ Review 2025: Does It Really Work For Weight Loss? Ingredients, Side Effects & Real Results
GlobeNewswire
·
May 9, 2025
New York City, NY, May 09, 2025 (GLOBE NEWSWIRE) -- Due to the increase of toxins and chemical compounds in meals, weight loss has become a major concern in modern society. Not only do people forget to filter their food intake, but it frequently becomes …
4 Best Fat Burners for Women Over the Counter and Online 2025 - Top Fat Burning Supplements and Pills for Female Weight Loss - Wolfson Brands
GlobeNewswire
·
May 9, 2025
Glasgow, May 09, 2025 (GLOBE NEWSWIRE) -- Losing weight can be tough, especially when stubborn fat just doesn’t seem to budge. But here’s the good news: 2025 brings a new wave of powerful, over-the-counter fat burners and online supplements designed …
Safest Steroids - Best Legal Steroids For Muscle Growth (Bulking & Cutting) By CrazyBulk USA
GlobeNewswire
·
May 9, 2025
New York City, NY, May 09, 2025 (GLOBE NEWSWIRE) -- In bodybuilding, wanting to get significant growth of strength and muscle in a really short period of time will make the user resort to anabolic steroids. The ensuing medical dangers and illegality make …
Nelipak® Healthcare Packaging to Expand Operations in Costa Rica
GlobeNewswire
·
May 9, 2025
CRANSTON, R.I., May 09, 2025 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak®”), a leading global provider of healthcare packaging solutions for medical device, diagnostic, pharmaceutical drug delivery, and other demanding applications, announced that …
SRx Health Solutions Announces Intention to Create Subsidiary for Crypto-Based Borrowing
GlobeNewswire
·
May 9, 2025
TAMPA, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced its intention to create a subsidiary to borrow Solana, Bitcoin, and other …
Cytel Partners with Nested Knowledge to Power the Next Generation of AI-Enhanced LiveSLR® for HEOR and HTA
GlobeNewswire
·
May 9, 2025
Cambridge, MA and St. Paul, MN, May 09, 2025 (GLOBE NEWSWIRE) -- Cytel, a global leader in evidence generation and data-driven decision-making, today announced a partnership with Nested Knowledge, a pioneer in AI-powered systematic literature review …
LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia
GlobeNewswire
·
May 9, 2025
SAN DIEGO and TAIPEI, Taiwan, May 09, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Lotus Pharmaceutical Co., Ltd. (“Lotus”, TWSW Stock Code: 1795) today announced an exclusive license and commercialization agreement for Lotus to …
SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates
GlobeNewswire
·
May 9, 2025
MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the …
Outset Medical to Present at RBC Global Healthcare Conference
GlobeNewswire
·
May 9, 2025
SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of …
NEXGEL to Report First Quarter 2025 Financial Results on May 13th
GlobeNewswire
·
May 9, 2025
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for …
SRx Health Solutions Purchases $1.5 Million of Solana Tokens as Part of its Asset Allocation Diversification Strategy
GlobeNewswire
·
May 9, 2025
TAMPA, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced purchasing Solana Tokens (SOL) for approximately $1.5 million as part of the …
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
GlobeNewswire
·
May 9, 2025
Conduit secures a composition of matter patent from the Korean Intellectual Property Office for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and strategic partnerships. …
Ocugen Provides Business Update with First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026 Anticipate initiating OCU410ST Phase 2/3 pivotal confirmatory clinical …
BlossomHill Therapeutics Appoints Jason Keyes as Chief Financial Officer and Executive Vice President
GlobeNewswire
·
May 9, 2025
SAN DIEGO, May 09, 2025 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, today …
Garuda Therapeutics Announces Name Change to Stratus Therapeutics to Reflect Mission of Pioneering Full Hematopoietic System Renewal
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Garuda Therapeutics (“Garuda”), a biotechnology company developing off-the-shelf hematopoietic stem cell (HSC) therapies, today announced that it has changed its name to Stratus Therapeutics, Inc. (“ …
PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights
GlobeNewswire
·
May 9, 2025
Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors Interim analysis from Phase 2 PYNNACLE trial expected mid-2025; PMV plans to …
Spectral Medical Announces First Quarter and Provides Corporate Update
GlobeNewswire
·
May 9, 2025
Tigris Trial Enrollment completed Topline results expected to be released in August 2025 Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Spectral Medical …